Concepedia

Cancer immunotherapy by fusions of dendritic and tumour cells and rh‐IL‐12

Sadamu Homma, Tetsuro Kikuchi, N. Ishiji, Kazuhiko Ochiai, Hiroshi Takeyama, Hideo Saotome, Yukiko Sagawa, Eiichi Hara, Donald Küfe, John L. Ryan,

European Journal of Clinical Investigation · 2005 · 32 citations · 26 references

DOI

Abstract

Immunotherapy using a FC vaccine and rhIL-12 induced no serious adverse reactions, and provided good therapeutic responses in some of the patients with a brain tumour.

References

26

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Federica Sallusto, Antonio Lanzavecchia · The Journal of Experimental Medicine · 1994 · 5.1K citations · Full text

, , +19

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

Christina M. Celluzzi, José Mayordomo, Walter J. Storkus et al. · The Journal of Experimental Medicine · 1996 · 732 citations · Full text

, , +14

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

Dongshu Chen, Masahiro Kashiwaba, Donald Küfe · Nature Medicine · 1997 · 602 citations

, , +11

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Michael B. Atkins, Michael J. Robertson, Michael S. Gordon et al. · PubMed · 1997 · 590 citations

, , +19

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

Paul F. Robbins, Mona El‐Gamil, Yongfeng Li et al. · The Journal of Experimental Medicine · 1996 · 547 citations · Full text

, , +18